batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. No Truqap déjà vu in triple-negative breast cancer 18 June 2024 Piccolo points the way to earlier Elahere use 7 June 2024 The markets bet on a Geron buyout 7 June 2024 Jazz sets zani sights on a post-Enhertu world 5 June 2024 PureTech has company in galectin-9 5 June 2024 ASCO 2024 – Yervoy makes the difference in front-line liver cancer 4 June 2024 ASCO 2024 – IDRx shoots for an early-line gist 3 June 2024 ASCO 2024 – acasunlimab impresses on overall survival 2 June 2024 Load More